WIM
COLL icon

WealthPlan Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

WealthPlan Investment Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,859
Closed -$40K – 195
2023
Q2 		$40K Hold
1,859
– – 0.01% 208
2023
Q1 		$44.6K Buy
+1,859
New +$49.3K 0.01% 254

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

WealthPlan Investment Management's COLL Position: Q3 2023 in Review

WealthPlan Investment Management sold out of Collegium Pharmaceutical (COLL) in Q3 2023, closing a stake of 1,859 shares — an estimated $40K sold.

WealthPlan Investment Management first reported a position in COLL in Q1 2023 and held it in 2 quarters. The position peaked at $44.6K in Q1 2023. 174 funds tracked by Wall St. Rank hold COLL as of Q3 2023.

  • WealthPlan Investment Management reported no remaining Collegium Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • WealthPlan Investment Management sold 1,859 Collegium Pharmaceutical shares in Q3 2023, an estimated $40K.
  • WealthPlan Investment Management first reported a position in Collegium Pharmaceutical in Q1 2023 and held it in 2 quarters.
  • WealthPlan Investment Management's Collegium Pharmaceutical position peaked at $44.6K in Q1 2023.
  • 174 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2023.

Based on WealthPlan Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.